NCT01707953View on ClinicalTrials.gov

Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Postoperative Orthostatic HypotensionPostoperative Orthostatic Intolerance
Interventions
DRUG

Midodrine

Midodrine 5mg as capsule, administered twice (5 and 23 hours after end of surgery).

DRUG

Placebo

Placebo capsule to mimic midodrine

Trial Locations (3)

2650

Hvidovre Hospital, Department of orthopaedic surgery, Hvidovre

2900

Gentofte Hospital, Department of orthopaedic surgery, Hellerup

7100

Vejle Sygehus, Department of orthopedic surgery, Vejle

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT01707953 - Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty | Biotech Hunter | Biotech Hunter